News Category
New independent research suggests cross-reactive immune responses to ebolaviruses, supporting the strategic value of GeoVax's MVA-based multi-antigen ...
Regentis Biomaterials is advancing its GelrinC platform to address a major unmet need in cartilage repair, offering a cell-free, single-step procedure...
Quantum BioPharma's pilot MS imaging study with Massachusetts General Hospital has reached halfway enrollment with encouraging preliminary data, poten...
NeuroThera Labs successfully demonstrated a complete hybrid quantum-classical workflow for clinical data analytics, marking a significant step toward ...
NeuroOne released a white paper detailing its StereoCED platform designed to streamline brain drug delivery using robotic stereotactic systems, aiming...
VERAXA Biotech has appointed Dr. Christoph Erkel as Chief Scientific Officer to lead the advancement of its proprietary BiTAC® technology platform and...
Onco-Innovations Limited closed a CAD$5 million private placement with Sorbie Bornholm LP and Sorbie Investments LLP to fund its ONC010 program and Sy...
Lexaria Bioscience announces a reverse stock split effective August 3, 2026, aimed at increasing share price to meet Nasdaq's minimum bid requirement ...
VolitionRx announced mounting clinical evidence for its Nu.Q NETs assay as a sepsis biomarker, with studies showing it can distinguish sepsis from non...
Instinct Bio announces a strategic collaboration with INVITRX to manufacture and sell GENREVER cosmetics in the U.S. and supply exosomes for Indonesia...
Renaissance BioScience Corp. appoints Dr. James Tansey, a serial entrepreneur and professor at UBC Sauder School of Business, to its board, bringing e...
Dr. Sven K. Weber will succeed Adriaan Moelker as CEO of BRAIN Biotech AG effective October 1, 2026, bringing expertise in industrial enzymes to accel...
VERAXA Biotech has expanded its intellectual property portfolio with new patent filings for its BiTAC and ADC platforms, extending protection through ...
MindBio Therapeutics has delivered its first Edge AI Intoxication and Fatigue Detection Kiosk prototypes, using voice analysis to screen for impairmen...
VERAXA Biotech strengthens its scientific leadership with Dr. Christoph Erkel as new CSO, positioning the company to advance its BiTAC(R) platform and...
VERAXA Biotech AG announced the expansion of its intellectual property portfolio with new patent filings covering its BiTAC-TCE and BiTAC-ADC platform...
Greenland Mines (NASDAQ: GRML) announced a Canadian patent for its Klotho-based gene therapy technology, expanding its IP portfolio and advancing lead...
Quantum BioPharma's executive outlined plans for Lucid-MS, a potential multiple sclerosis treatment filing for Phase 2 trials, and highlighted the com...
VERAXA Biotech shareholders approved proposals to enhance corporate governance and financing flexibility, supporting the company's long-term growth st...
Greenland Mines Ltd. (NASDAQ: GRML) has been granted a Canadian patent for Klotho-based gene therapies targeting cognition, memory and neurodegenerati...
NanoViricides has submitted an application to begin a Phase II trial of its NV-387 Oral Gummies for Bundibugyo ebolavirus in the DRC, where no approve...
Lantern Pharma's LP-184 trial cleared by EMA for biomarker-guided Phase 1b/2 study in advanced bladder cancer patients with PTGR1 overexpression and D...
GeoVax Labs advances its GEO-MVA vaccine toward a pivotal immunobridging study under an expedited EMA pathway, while discontinuing its COVID-19 vaccin...
VERAXA Biotech announced the advancement of its bispecific antibody-drug conjugate program VXA-222 after OmniAb completed discovery work, moving the p...
The article details Quantum BioPharma's strategy for advancing its lead MS drug candidate Lucid-MS into Phase 2 trials and its commercial product unbu...
Onco-Innovations Limited is progressing its lead PNKP inhibitor ONC010 through manufacturing scale-up and strategic partnerships, positioning it for f...
Tonix Pharmaceuticals will report Q2 2026 financial results and operational highlights on Aug. 10, 2026, followed by a conference call, providing upda...
VERAXA Biotech has advanced its bispecific antibody-drug conjugate program VXA-222, leveraging OmniAb's discovery technologies to target solid tumors ...
Onco-Innovations is integrating a novel DNA repair target, nanoparticle delivery, and artificial intelligence to address key challenges in oncology dr...
VERAXA Biotech AG appoints Christoph Erkel as CSO to lead development of its BiTAC platform for solid tumor therapies, signaling a strategic push towa...
VERAXA Biotech has obtained scientific advice from Germany’s Paul-Ehrlich-Institute supporting its development strategy for its lead BiTAC®-TCE candid...
Onco-Innovations is developing ONC010, a nanoparticle-encapsulated PNKP inhibitor for biomarker-selected cancers, aligning with the shift toward preci...
Lantern Pharma's receipt of a U.S. patent allowance for its LP-184 biomarker-based treatment methods underscores the role of AI in precision oncology ...
VERAXA Biotech AG (NASDAQ: VRXA) announced the appointment of Christoph Erkel, Ph.D., as Chief Scientific Officer, effective immediately, to lead the ...
iOrganBio strengthens its Scientific Advisory Board with Harvard stem cell expert Lee L. Rubin, Ph.D., to accelerate neurological applications of its ...
BioAdaptives (OTC: BDPT) has finished commercial manufacturing and supply chain preparations to launch its MyndSystem cognitive performance and Xcella...
Creative Biolabs has expanded its integrated microfluidics solutions, combining droplet generation systems and customizable chips to improve throughpu...
Quantum BioPharma (QNTM) is advancing two novel treatments—Lucid-MS for multiple sclerosis and unbuzzd for alcohol intoxication—addressing significant...
Oncotelic Therapeutics announced the publication of preclinical data for its intravenous everolimus formulation Sapu003, which addresses pharmacokinet...
Kairos Pharma has partnered with Bayer to test its antibody ENV-105 with XOFIGO for metastatic castration-resistant prostate cancer, aiming to overcom...
VERAXA Biotech has obtained Scientific Advice from Germany's Paul-Ehrlich-Institute supporting the development strategy for its lead BiTAC(R)-TCE prog...
VivoSim Labs secured $4 million from a single healthcare investor, with proceeds earmarked for working capital and corporate purposes, signaling confi...
Greenwich LifeSciences reports positive DSMB review and expanded study design for its Phase 3 FLAMINGO-01 trial of GLSI-100, which aims to prevent bre...
Quantum BioPharma is advancing treatments for multiple sclerosis and alcohol intoxication, targeting significant unmet needs in neurological disorders...
American Fusion Inc. received a Texas DSHS Certificate of Registration allowing R&D on its Texatron Fusion Engine systems at Texas Tech University, ad...
A comprehensive review commissioned by the World Health Organization found no evidence that mobile phone use causes brain cancer, potentially alleviat...
Quantum BioPharma announces halfway patient enrollment in a pilot imaging study for multiple sclerosis, with early data showing a meaningful signal in...
GeoVax's GEO-MVA vaccine platform aligns with ASPR's priorities for domestic manufacturing, platform technologies, and pandemic preparedness, supporti...
